Cypress Asset Management Inc. TX acquired a new position in Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 16,151 shares of the conglomerate's stock, valued at approximately $3,728,000.
Several other institutional investors and hedge funds have also made changes to their positions in DHR. Kentucky Retirement Systems Insurance Trust Fund raised its position in shares of Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock valued at $4,874,000 after buying an additional 2,202 shares during the period. FAS Wealth Partners Inc. raised its position in shares of Danaher by 20.6% during the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after buying an additional 1,639 shares during the period. Generate Investment Management Ltd purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $8,044,000. Compass Capital Management Inc. raised its position in Danaher by 4.8% in the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock valued at $54,615,000 after purchasing an additional 10,994 shares during the period. Finally, Channing Global Advisors LLC raised its position in Danaher by 42.8% in the fourth quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate's stock valued at $1,301,000 after purchasing an additional 1,698 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Danaher
In other news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on DHR. Guggenheim reissued a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Robert W. Baird cut their price objective on Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Wells Fargo & Company cut their price objective on Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research report on Thursday, January 30th. Finally, Jefferies Financial Group cut their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $263.24.
Get Our Latest Stock Analysis on DHR
Danaher Stock Up 0.7%
Shares of DHR traded up $1.37 during mid-day trading on Thursday, hitting $190.38. 2,814,459 shares of the company's stock were exchanged, compared to its average volume of 3,470,766. The firm has a fifty day moving average of $193.63 and a two-hundred day moving average of $214.49. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The stock has a market cap of $136.25 billion, a price-to-earnings ratio of 36.06, a P/E/G ratio of 2.66 and a beta of 0.80. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. On average, sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.67%. Danaher's dividend payout ratio is currently 24.85%.
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
